Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?

Cindy W. Wong, Thomas Christen, Anna Pfenniger, Richard W. James, Brenda R. Kwak*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

A C1019T polymorphism in the human connexin37 (hCx37) gene has been associated with cardiovascular risk, but it remains debatable whether the 1019C or the 1019T allele carries this risk. Here, we investigated whether these allelic variants are differentially predictive of increased risk for coronary artery disease (CAD) and myocardial infarction (MI). A total of 781 Swiss participants, including 597 patients diagnosed with CAD, 50% who reported previous MI, and 184 control subjects were genotyped. Patients in the +CAD group had a higher frequency of the Cx37-1019C allele (70.3% versus 65.0%, p = 0.004). Multivariate analysis showed that the hCx37-C1019T polymorphism is an independent predictor of CAD (odds ratio = 2.13, confidence interval = 1.31-3.46 and p < 0.01). Moreover, this polymorphism is not associated with any of the other characteristics examined, including gender, age, body-mass-index, diabetes, total/HDL/LDL-cholesterol, triglycerides, apoA-I, apoB, hypertension and cigarette smoking. In comparison with the -CAD group, we observed an increase of the Cx37-1019C allele in the +MI +CAD subgroup (71.2% versus 65.0%, p = 0.002) but not in the -MI +CAD subgroup. Allelic frequency comparisons of these three subgroups predicted that this polymorphism is also an independent risk factor for MI. In conclusion, our results reveal the importance of screening the Cx37-1019C allele for both CAD and MI risk assessments.

Original languageEnglish (US)
Pages (from-to)355-361
Number of pages7
JournalAtherosclerosis
Volume191
Issue number2
DOIs
StatePublished - Apr 2007

Funding

This work was supported by grants from the Swiss National Science Foundation #PPOOA-68883 and #3100-067777 (to BRK) and #31-105310 (to RWJ), the ‘Fondation Novartis’ (to BRK), the Novartis Consumer Health Foundation (to CWW and BRK) and the Swiss University Conference Program ‘Heart Remodeling in Health and Disease’ (to BRK).

Keywords

  • Atherosclerosis
  • Connexin
  • Coronary artery disease
  • Genetic polymorphism
  • Myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?'. Together they form a unique fingerprint.

Cite this